Effectiveness of Aqueous Hibiscus Sabdariffa Extract on Reduction of Blood Pressure and Serum Lipids Among Prehypertensive Patients
- PMID: 39346261
- PMCID: PMC11426887
- DOI: 10.4103/jpbs.jpbs_554_24
Effectiveness of Aqueous Hibiscus Sabdariffa Extract on Reduction of Blood Pressure and Serum Lipids Among Prehypertensive Patients
Abstract
Pre-experimental one group pertest post-test research design was adopted to investigate the effectiveness of aqueous flower extract of Hibiscus sabdariffa in reduction of blood pressure, serum lipids among 60 prehypertensive patients. A self-structured questionnaire and manual sphygmomanometer and stethoscope monitored blood pressure levels before and after administering Hibiscus sabdariffa extract. Results showed a significant drop in blood pressure levels among prehypertensive patients with a mean difference score of 12.75, and a substantial decrease in total cholesterol, triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very low density lipoprotein (VLDL) levels. The calculated paired 't' test value of 16.280 was statistically significant at P < 0.001 level, indicating that oral supplementation of Hibiscus sabdariffa's flower extract is effective in reducing blood pressure and serum cholesterol in prehypertensive patients.
Keywords: Aqueous flower extract; Hibiscus sabdariffa; blood pressure; prehypertensive patients; reduction; serum lipids.
Copyright: © 2024 Journal of Pharmacy and Bioallied Sciences.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Al-Snafi AE. Blood lipids lowering effect of medicinal plants. GSC Biol Pharm Sci. 2022;19:015–43.
-
- Gaffer EY, Mustafa HA. The Hypolipidaemic effect of the ethanolic extract of Hibiscus sabdariffa L. calyces on induced hyperlipidaemia in Albino rats. EC Veterin Sci. 2019;4:379–86.
-
- Jaisamut P, Tohlang C, Wanna S, Thanakun A, Srisuwan T, Limsuwan S, et al. Clinical evaluation of a novel tablet formulation of traditional thai polyherbal medicine named Nawametho in comparison with its decoction in the treatment of Hyperlipidemia. Evid Based Complement Alternat Med 2022. 2022:2530266. - PMC - PubMed
LinkOut - more resources
Full Text Sources